Remove Cardiothoracic Remove Pulmonary Remove Research
article thumbnail

Patients Who Received Ross Procedure Demonstrate Excellent Survival Rates after 20 Years

Society of Thoracic Surgeons - Adult Cardiac

During the surgery, the malfunctioning aortic valve is replaced with the patients own healthy pulmonary valvea technique called an autograftand the pulmonary valve replaced with donor tissue. Three patients underwent the Ross-Konno procedure, in which the left-sided outflow root is enlarged to fit the pulmonary autograft.

article thumbnail

Impact of aortic and pulmonary artery wall histology on radicular dilatation during the Ross procedure

Journal of Cardiothoracic Surgery

In our study, we aim to explore the structural differences between the aortic root and the pulmonary artery to better understand the process of pulmonary autograft dilatation during the Ross procedure.

article thumbnail

Research progress on the association between lung cancer and pulmonary embolism

Journal of Cardiothoracic Surgery

Pulmonary embolism (PE), a form of venous thromboembolism, is a frequently observed complication in malignancies, with a notably high incidence in individuals with lung cancer. The presence of PE markedly redu.

article thumbnail

Insight into the research history and trends of total anomalous pulmonary venous connection: a bibliometric analysis

Journal of Cardiothoracic Surgery

Total anomalous pulmonary venous connection (TAPVC) is a rare congenital heart disease characterized by the inability of all pulmonary veins to connect to the left atrium. Our previous bibliometric article sum.

article thumbnail

ECG changes following balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a retrospective study

Journal of Cardiothoracic Surgery

This research evaluates the effect of balloon pulmonary angioplasty (BPA) on cardiac electrophysiological changes in patients with chronic thromboembolic pulmonary hypertension (CTEPH).

article thumbnail

New Treatment Options Available for Patients with Tricuspid Valve Disease

DAIC

13, 2025 Research from Cedars-Sinai investigators and collaborators at other leading medical institutions is helping to provide more treatment options to people living with tricuspid valve disease. Image by Getty. tim.hodson Tue, 02/18/2025 - 10:08 Feb.

article thumbnail

Riverain Technologies Launches New FDA-Cleared Technology, Expands Globally

DAIC

4, 2025 Riverain Technologies recently announced it expanded across eight countries in 2024 and added nearly 50 new customers with its ClearRead solutions to clearly, confidently and quickly detect cardiothoracic diseases. tim.hodson Tue, 02/04/2025 - 16:21 Feb.4,